Business law.The researches crafted by our business law case study help writers are 100 % unique and contain the most relevant data ensuring you are receiving the best scores every time. As many of our case study writers work or have previously served in prestigious universities, they bring full insight into the thought process of a professor when reviewing each assignment that the students have posted. It helps our division of proof reading to evaluate the areas which can be improved from the standpoint of a professor and make improvements in them.

Question 16 What is the latest recommended drug treatment for hepatitis C?

Question 17 Can hepatitis C disease be treated in a carrier state completely by giving interferon?

Question 18 I am a carrier of hepatitis C (HCV) and am going to have antiviral treatment soon. Are the side-effects of antiviral treatment for HCV bound to occur? I am very worried.

Question 19 Besides needle-pricks, how else is it possible to contract hepatitis C from a hepatitis C (HCV)-positive patient? Are the patient's skin/sweat (or other bodily secretions) infectious?

Question 20 What is the risk of infection with hepatitis C from blood splashed into the eyes?

Question 21 Hepatitis C (HCV): if results from the polymerase chain reaction (PCR) examination are inconclusive, what does this mean? Should further investigations be undertaken and, if so, will there be a risk of chronicity?

Question 22 In a patient with hepa titis C and autoimmune hepatitis, can corticosteroids be prescribed for the autoimmune hepatitis?

Question 23 We were told that the more vascular a structure is, the more antigen (HLA/blood groups) matching is needed for transplantation, e.g. cornea transplant needs no matching. However, the liver is a very vascular organ; I don't know why liver transplantation needs blood group matching only but renal transplantation needs much more HLA matching.

Question 24 About steatohepatitis: please give me more information about the occurrence of cirrhosis in such patients (non-alcoholic) and is there any role and indication for lipotropic agents and hypocholesterolaemic drugs?

Question 25 I am working on non-alcoholic fatty liver disease (NAFLD) but I did not find anything regarding it. Can you tell me about its relationship with lipids?

Question 26 Is NASH a valid term or not and what manifestation has it?